Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lenvatinib + Stupp Regimen in Newly Diagnosed MGMT-Methylated Glioblastoma
NCT07754734Phase 2Not yet recruiting
- Sponsor
- Dongguan People's Hospital
- Start
- Aug 2026
- Primary completion
- Jul 2029
01
Overview
A Phase 2 trial of lenvatinib in glioblastoma (GBM), sponsored by Dongguan People's Hospital. Planned start Aug 2026; status: not yet recruiting.
02
Drugs
lenvatinib
03
Conditions
glioblastoma (GBM)
Beyond the preview
Go deeper on NCT07754734.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07754734.